My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 485

    1.

    Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice.

    Martin AP, Grisotto MG, Canasto-Chibuque C, Kunkel SL, Bromberg JS, Furtado GC, Lira SA.

    Diabetes. 2008 Feb;57(2):387-94. Epub 2007 Nov 14.PMID: 18003753 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The chemokine binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin.

    Martin AP, Alexander-Brett JM, Canasto-Chibuque C, Garin A, Bromberg JS, Fremont DH, Lira SA.

    J Immunol. 2007 Apr 1;178(7):4623-31.PMID: 17372021 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.

    Silva DG, Petrovsky N, Socha L, Slattery R, Gatenby P, Charlton B.

    J Immunol. 2003 May 15;170(10):4996-5002.PMID: 12734343 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.

    Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL.

    Diabetologia. 2003 Feb;46(2):255-66. Epub 2003 Feb 12.PMID: 12627325 [PubMed - indexed for MEDLINE]Related articles

    5.

    Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis.

    Fox CJ, Paterson AD, Mortin-Toth SM, Danska JS.

    Am J Hum Genet. 2000 Jul;67(1):67-81. Epub 2000 Jun 9.PMID: 10848492 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Interleukin-21 is required for the development of type 1 diabetes in NOD mice.

    Sutherland AP, Van Belle T, Wurster AL, Suto A, Michaud M, Zhang D, Grusby MJ, von Herrath M.

    Diabetes. 2009 May;58(5):1144-55. Epub 2009 Feb 10.PMID: 19208913 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.

    Chong MM, Chen Y, Darwiche R, Dudek NL, Irawaty W, Santamaria P, Allison J, Kay TW, Thomas HE.

    J Immunol. 2004 May 1;172(9):5714-21.PMID: 15100317 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.

    Ejrnaes M, Videbaek N, Christen U, Cooke A, Michelsen BK, von Herrath M.

    J Immunol. 2005 Mar 1;174(5):2746-55.PMID: 15728483 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Glucocorticoid receptor expression is altered in pancreatic beta cells of the non-obese diabetic mouse during postnatal development.

    Thompson A, Arany EJ, Hill DJ, Yang K.

    Metabolism. 2002 Jun;51(6):765-8.PMID: 12037732 [PubMed - indexed for MEDLINE]Related articles

    10.

    On the pathogenicity of autoantigen-specific T-cell receptors.

    Burton AR, Vincent E, Arnold PY, Lennon GP, Smeltzer M, Li CS, Haskins K, Hutton J, Tisch RM, Sercarz EE, Santamaria P, Workman CJ, Vignali DA.

    Diabetes. 2008 May;57(5):1321-30. Epub 2008 Feb 25.PMID: 18299317 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.

    Leijon K, Hillörn V, Bergqvist I, Holmberg D.

    J Autoimmun. 1995 Jun;8(3):347-56.PMID: 7575996 [PubMed - indexed for MEDLINE]Related articles

    12.

    Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes: role of IFNbeta.

    Planas R, Alba A, Carrillo J, Puertas MC, Ampudia R, Pastor X, Okamoto H, Takasawa S, Gurr W, Pujol-Borrell R, Verdaguer J, Vives-Pi M.

    Diabetologia. 2006 Oct;49(10):2379-87. Epub 2006 Aug 10.PMID: 16900387 [PubMed - indexed for MEDLINE]Related articles

    13.

    Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes.

    Walter U, Franzke A, Sarukhan A, Zober C, von Boehmer H, Buer J, Lechner O.

    Eur J Immunol. 2000 Apr;30(4):1224-32. Erratum in: Eur J Immunol. 2003 Jul;33(7):2064. Frantzke A [corrected to Franzke A]. PMID: 10760812 [PubMed - indexed for MEDLINE]Related articles

    14.

    Immunoexpression of interleukin-1beta in pancreatic islets of NOD mice during cyclophosphamide-accelerated diabetes: co-localization in macrophages and endocrine cells and its attenuation with oral nicotinamide.

    Reddy S, Young M, Ginn S.

    Histochem J. 2001 Jun;33(6):317-27.PMID: 11758808 [PubMed - indexed for MEDLINE]Related articles

    15.

    Expression of somatostatin receptor subtypes 1-5 in pancreatic islets of normoglycaemic and diabetic NOD mice.

    Ludvigsen E, Stridsberg M, Janson ET, Sandler S.

    Eur J Endocrinol. 2005 Sep;153(3):445-54.PMID: 16131608 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Islet mass plays a critical role in initiation, but not progression, of the diabetogenic process in NOD mice.

    Kimura T, Ito A, Hancock WW, Maki T.

    J Autoimmun. 1999 Jun;12(4):243-9.PMID: 10330295 [PubMed - indexed for MEDLINE]Related articles

    17.

    Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes.

    Pechhold K, Zhu X, Harrison VS, Lee J, Chakrabarty S, Koczwara K, Gavrilova O, Harlan DM.

    Diabetes. 2009 May;58(5):1175-84. Epub 2009 Feb 19.PMID: 19228810 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development.

    Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L.

    J Immunol. 2004 Aug 15;173(4):2280-7.PMID: 15294940 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Role of L-selectin in the development of autoimmune diabetes in non-obese diabetic mice.

    Mora C, Grewal IS, Wong FS, Flavell RA.

    Int Immunol. 2004 Feb;16(2):257-64.PMID: 14734611 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice.

    Gysemans CA, Cardozo AK, Callewaert H, Giulietti A, Hulshagen L, Bouillon R, Eizirik DL, Mathieu C.

    Endocrinology. 2005 Apr;146(4):1956-64. Epub 2005 Jan 6.PMID: 15637289 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity